Evaluating the utility of a patient and public involvement and engagement (PPIE) end-of-trial event to re-engage with cell-based therapy participants
This study highlights the importance of integrating participant perspectives to optimize trial design and delivery in future cell therapy research.
Authors
- Michael T. Murphy (ORCID: https://orcid.org/0000-0003-2080-675X)
- Geethu Emily Thomas (ORCID: https://orcid.org/0000-0002-8737-1394)
- Karina T. Wright (ORCID: https://orcid.org/0000-0001-8842-5908)
- Andrea Bailey
- Charlotte Hulme (ORCID: https://orcid.org/0000-0002-4961-2185)
- Andrew Roberts (ORCID: https://orcid.org/0000-0002-5351-6567)
- Peter Gallacher (ORCID: https://orcid.org/0000-0003-1360-1369)
- Deepak Menon (ORCID: https://orcid.org/0000-0001-6722-5405)
- Jan-Herman Kuiper
- Paul Jermin
- Yumna Ladha
Institutions
- Robert Jones and Agnes Hunt Orthopaedic Hospital (GB)
- Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Trust (GB)
- Keele University (GB)
Publication Details
- Journal
- Regenerative Medicine
- Published
- 2025-12-02
- DOI
- https://doi.org/10.1080/17460751.2025.2601546
- Primary Topic
- Biomedical Ethics and Regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00